GSK plc (GSK) Latest News

NYSE Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$32.08

south_east

-$0.63 (-1.91%)

Day's range

$31.72

$32.28

Latest News of GSK

GSK plc (GLAXF) Stock Price, News, Quote & History

GSK plc (GLAXF) Stock Price, News, Quote & History

By Yahoo! Finance | 1 day ago

GSK to buy US cancer drug firm IDRx for up to $1.15bn

GSK to buy US cancer drug firm IDRx for up to $1.15bn

By The Guardian | 1 day ago

JP Morgan 2025: GSK acquires IDRx in $1.15bn deal

JP Morgan 2025: GSK acquires IDRx in $1.15bn deal

By Yahoo! Finance | 1 day ago

Pound slides to fresh 14-month low; GSK buys US cancer firm for $1.15bn - business live

Pound slides to fresh 14-month low; GSK buys US cancer firm for $1.15bn - business live

By The Guardian | 1 day ago

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

By Yahoo! Finance | 1 week ago

China's NMPA approves GSK's Nucala for CRSwNP treatment

China's NMPA approves GSK's Nucala for CRSwNP treatment

By Yahoo! Finance | 1 week ago

GSK's Nucala Gains Approval in China for CRSwNP

GSK's Nucala Gains Approval in China for CRSwNP

By Yahoo! Finance | 1 week ago

GSK's Sinus Disease Drug Secures Approval In China

GSK's Sinus Disease Drug Secures Approval In China

By Yahoo! Finance | 1 week ago

Muna-GSK alliance to fast-track Alzheimer's disease treatments

Muna-GSK alliance to fast-track Alzheimer's disease treatments

By Yahoo! Finance | 1 month ago

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago

By Yahoo! Finance | 1 month ago

GSK gains approval in Japan for extended indication of RSV vaccine

GSK gains approval in Japan for extended indication of RSV vaccine

By Yahoo! Finance | 1 month ago

GSK eyes up combo approval for previously withdrawn myeloma drug

GSK eyes up combo approval for previously withdrawn myeloma drug

By Yahoo! Finance | 1 month ago

GSK announces Japan's MHLW approved application to extend indication of Arexvy

GSK announces Japan's MHLW approved application to extend indication of Arexvy

By Yahoo! Finance | 1 month ago